In correlation with this hypothesis, recent studies show that the expression of metalloprotease MMP9 from the tumour surrounding stroma, unlike its expression in tumour cell cytoplasm, correlates with unfavourable prognosis in ERBB2 positive breast cancer [38]. The gene discussed is ERBB2; the disease is neoplasm.